Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
Prof Karl Claxton from the University of York believes this to be the case https://lnkd.in/dHrZSty
The first EU Joint Clinical Assessment (JCA) has now been published, providing the first practical i...
Read moreExpert contributions are critical to health technology assessment (HTA), particularly in rare diseas...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch